Specifically, the median NT-proBNP concentration and proportion of patients with elevated NT-proBNP concentration were the greatest in patients with high-grade glioma, meningioma and metastatic brain tumors, relative to patients with low-grade glioma, vestibular schwannoma and meningioma. The gene discussed is NPPB; the disease is glioma.